EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Malignant Meningiomas: From Diagnostics to Treatment

Hojka Rowbottom, Tomaž Šmigoc iD, Janez Ravnik

Diagnostics · 23.02.2025 · 15 (5) · 538

DOI: 10.3390/diagnostics15050538 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 23.02.2025. Verfasst von Hojka Rowbottom und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Centre Maribor, 2000 Maribor, Slovenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Meningiomas account for approximately 40% of all primary brain tumors, of which 1.5% are classified as grade 3. Whilst meningiomas are discovered on imaging with high-grade meningiomas being associated with certain imaging features, the final diagnosis is based on histopathology in combination with molecular markers. According to the latest World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS), grade 3 should be assigned based on criteria for anaplastic meningiomas, which comprise malignant cytomorphology (anaplasia) that resembles carcinoma, high-grade sarcoma or melanoma; elevated mitotic activity; a TERT promoter mutation and/or a homozygous CDKN2A and/or CDKN2B deletion. Surgery remains the mainstay treatment modality for grade 3 meningiomas, followed by radiotherapy. Limited data are available on the effect of stereotactic radiosurgery and systemic therapy for grade 3 meningiomas; however, studies are underway. Despite optimal treatment, the estimated recurrence rate ranges between 50% and 95% with a 5-year survival rate of 66% and a 10-year estimated survival rate of 14% to 24%.

Schlagwörter

Stichwörter der Autor:innen

DNS methylation profilingPET SSTR ligandsSimpson gradeadjuvant radiotherapygeneticsmalignant meningiomas

Autor:innen und Institutionen

  • Department of Neurosurgery, University Medical Centre Maribor, 2000 Maribor, Slovenia.

ORCID-Profile: Tomaž Šmigoc

Zitieren

APA

Rowbottom, H., Šmigoc, T., & Ravnik, J. (2025). Malignant Meningiomas: From Diagnostics to Treatment. Diagnostics, 15(5), 538. https://doi.org/10.3390/diagnostics15050538

Vancouver

Rowbottom H, Šmigoc T, Ravnik J. Malignant Meningiomas: From Diagnostics to Treatment. Diagnostics. 2025;15(5):538. doi:10.3390/diagnostics15050538

BibTeX
@article{Rowbottom2025,
  author = {Rowbottom, Hojka and Šmigoc, Tomaž and Ravnik, Janez},
  title = {Malignant Meningiomas: From Diagnostics to Treatment},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {538},
  doi = {10.3390/diagnostics15050538}
}
Kostenlos starten →